Still struggling with recurring dry eye symptoms linked to meibomian gland dysfunction (MGD)? Artificial tears only offer temporary relief, leaving dryness and burning sensations to return? Good news is here! Our hospital has officially introduced Hengqin® Perfluorohexyloctane Eye Drops—the world's only approved innovative medication for MGD-related dry eye. This precision treatment offers a new solution for patients, now covered by medical insurance to ensure accessibility and affordability!

Dedicated Innovative Medication with Multiple Benefits for Dry Eye Patients

As a dedicated medication for MGD-related dry eye, perfluorohexyloctane eye drops are developed based on the world's first water-free drug delivery platform, EyeSol®. Composed solely of perfluorohexyloctane (F6H8), it is water-free and contains no excipients such as oils, surfactants, or preservatives. Its extremely low surface tension enables rapid diffusion across the ocular surface while improving lipid layer integrity, inhibiting tear evaporation, and promoting corneal epithelial repair. Additionally, perfluorohexyloctane eye drops replenish non-polar lipid components, increase tear film thickness, unblock meibomian glands, and enhance meibum secretion.

Clinical studies confirm this medication rapidly relieves dry eye symptoms like dryness and burning within 5 minutes, with significant corneal repair observed within 4 weeks. Its single ingredient, perfluorohexyloctane, exhibits exceptional inertness—being pure oil with no water, pH, or osmotic pressure—making it unsuitable for any microbial growth and thus eliminating the need for preservatives. Unlike water-based eye drops with a shelf life of only 1-3 months after opening, this medication remains effective for up to two years post-opening. Patients can use it throughout its expiration period without worrying about waste from short-term discontinuation leading to expiration.

Covered by Medical Insurance, Accessible and Affordable for Patients

This new medication is now officially included in the medical insurance catalog. The 3ml bottle is priced at 190 yuan, with direct reimbursement available through insurance, significantly reducing the financial burden on patients. It is particularly suitable for patients with moderate to severe MGD-related dry eye where traditional artificial tears are ineffective, or for those with markedly shortened tear breakup time (<5 seconds). It precisely addresses the treatment challenge of “hydrating but not locking in moisture” in evaporative dry eye.

Dongguan Aier Eye Hospital Comprehensive Ophthalmology Department Reminder:

Dry eye conditions vary widely. Perfluorohexyloctane eye drops are specifically designed for MGD-related dry eye and are not a universal solution for all dry eye patients! Individuals experiencing persistent dryness, foreign body sensation, burning, or other discomfort are advised to first undergo a professional dry eye examination at a hospital. After a doctor identifies the specific type and severity of dry eye, a personalized treatment plan can be developed to avoid unnecessary medication use.

Translated with DeepL.com (free version)